Guided Therapeutics (GTHP) Non Operating Income (2022 - 2025)
Guided Therapeutics (GTHP) posted Non Operating Income of -$48000.0 for Q2 2025, down 269.23% sequentially from -$13000.0 in Q1 2025, and up 11.11% YoY from -$43200.0 in Q2 2024.
Guided Therapeutics (GTHP) Non Operating Income (2022 - 2025) Analysis & Trends
Guided Therapeutics has reported Non Operating Income for 4 years, with the latest figure at -$48000.0 in Q2 2025.
- Quarterly Non Operating Income rose 11.11% year-over-year to -$48000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$272000.0 (down 423.08% YoY) and the FY2024 annual result came in at -$309000.0, down 865.62% from the prior year.
- Non Operating Income retreated to -$48000.0 in Q2 2025 per GTHP's latest filing, from -$13000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $122000.0 in Q3 2022 and troughed at -$859000.0 in Q4 2022.
- A 4-year average of -$103692.3 and a median of -$52000.0 in 2023 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2023 and 2024: Non Operating Income surged 111.53% in 2023, then tumbled 219.19% in 2024.
- Over 4 years, Non Operating Income stood at -$859000.0 in 2022, then surged by 111.53% to $99000.0 in 2023, then sank by 219.19% to -$118000.0 in 2024, then soared by 59.32% to -$48000.0 in 2025.
- According to Business Quant data, Non Operating Income over the past three periods registered -$48000.0, -$13000.0, and -$118000.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 46.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | - |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | -12.30 Mn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -48,000.00 |
| Mar 31, 2025 | -13,000.00 |
| Dec 31, 2024 | -118,000.00 |
| Sep 30, 2024 | -93,000.00 |
| Jun 30, 2024 | -54,000.00 |
| Mar 31, 2024 | -43,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Sep 30, 2023 | -54,000.00 |
| Jun 30, 2023 | -52,000.00 |
| Mar 31, 2023 | -26,000.00 |
| Dec 31, 2022 | -859,000.00 |
| Sep 30, 2022 | 122,000.00 |
| Jun 30, 2022 | -209,000.00 |